FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 318:1714-1719 June 30, 1988 Number 26 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To examine the role of antiplatelet therapy in the prevention of arterial restenosis after percutaneous transluminal coronary angioplasty (PTCA), we conducted a randomized, double-blind, placebo-controlled study in 376 patients. The active treatment consisted of an oral aspirin-dipyridamole combination (330 mg-75 mg) given three times daily, beginning 24 hours before PTCA. Eight hours before PTCA, the oral dipyridamole was replaced with intravenous dipyridamole at a dosage of 10 mg per hour for 24 hours, and oral aspirin was continued. Sixteen hours after PTCA, the initial combination was reinstituted. Treatment was continued in patients with a successfully dilated vessel until follow-up angiography four to seven months after PTCA--or earlier, if symptoms dictated. Of 249 patients who underwent follow-up angiography, 37.7 percent of patients receiving the active drug had restenosis in at least one segment, as compared with 38.6 percent of patients taking placebo (P not significant). The number of stenotic segments was virtually the same in the two groups. Among the 376 randomized patients, there were 16 periprocedural Q-wave myocardial infarctions--13 in the placebo group and 3 in the active-drug group (6.9 percent vs. 1.6 percent, P = 0.0113). Although the use of this antiplatelet regimen before and after PTCA did not reduce the six-month rate of restenosis after successful coronary angioplasty, it markedly reduced the incidence of transmural myocardial infarction during or soon after PTCA. Thus, the short-term use of antiplatelet agents in relation to PTCA can be recommended.

Source Information

Department of Cardiology, Montreal Heart Institute, Canada.

This article has been cited by other articles:

• Steinhubl, S. R., Berger, P. B. (2009). Aspirin following PCI: too much of a good thing?. Eur Heart J 30: 882-884 [Full Text]  
• Hopkins, J., Limacher, M. (2009). The Role of Aspirin in Cardiovascular Disease Prevention in Women. AMERICAN JOURNAL OF LIFESTYLE MEDICINE 3: 123-134 [Abstract]  
• Becker, R. C., Meade, T. W., Berger, P. B., Ezekowitz, M., O'Connor, C. M., Vorchheimer, D. A., Guyatt, G. H., Mark, D. B., Harrington, R. A. (2008). The Primary and Secondary Prevention of Coronary Artery Disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133: 776S-814S [Abstract] [Full Text]  
• Stone, G. W., Aronow, H. D. (2006). Long-term Care After Percutaneous Coronary Intervention: Focus on the Role of Antiplatelet Therapy. Mayo Clin Proc. 81: 641-652 [Abstract] [Full Text]  
• Steinhubl, S. R., Charnigo, R. (2006). Clopidogrel Treatment Prior to Percutaneous Coronary Intervention: When Enough Isn't Enough. JAMA 295: 1581-1582 [Full Text]  
• Marx, N., Wohrle, J., Nusser, T., Walcher, D., Rinker, A., Hombach, V., Koenig, W., Hoher, M. (2005). Pioglitazone Reduces Neointima Volume After Coronary Stent Implantation: A Randomized, Placebo-Controlled, Double-Blind Trial in Nondiabetic Patients. Circulation 112: 2792-2798 [Abstract] [Full Text]  
• Kelly, R V, Steinhubl, S (2005). Changing roles of anticoagulant and antiplatelet treatment during percutaneous coronary intervention. Heart 91: iii16-iii19 [Full Text]  
• Choi, D., Kim, S.-K., Choi, S.-H., Ko, Y.-G., Ahn, C.-W., Jang, Y., Lim, S.-K., Lee, H.-C., Cha, B.-S. (2004). Preventative Effects of Rosiglitazone on Restenosis After Coronary Stent Implantation in Patients With Type 2 Diabetes. Diabetes Care 27: 2654-2660 [Abstract] [Full Text]  
• McCaul, K A, Hobbs, M S T, Knuiman, M W, Rankin, J M, Gilfillan, I (2004). Trends in two year risk of repeat revascularisation or death from cardiovascular disease after coronary artery bypass grafting or percutaneous coronary intervention in Western Australia, 1980-2001. Heart 90: 1042-1046 [Abstract] [Full Text]  
• Popma, J. J., Berger, P., Ohman, E. M., Harrington, R. A., Grines, C., Weitz, J. I. (2004). Antithrombotic Therapy During Percutaneous Coronary Intervention: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest 126: 576S-599S [Abstract] [Full Text]  
• Ramanuja, S., Breall, J. A., Kalaria, V. G. (2004). Approach to "Aspirin Allergy" in Cardiovascular Patients. Circulation 110: e1-e4 [Full Text]  
• Wiviott, S. D., Antman, E. M. (2004). Clopidogrel Resistance: A New Chapter in a Fast-Moving Story. Circulation 109: 3064-3067 [Full Text]  
• Chen, W.-H., Lee, P.-Y., Ng, W., Tse, H.-F., Lau, C.-P. (2004). Aspirin resistance is associated with a high incidence of myonecrosis after non-urgent percutaneous coronary intervention despite clopidogrel pretreatment. J Am Coll Cardiol 43: 1122-1126 [Abstract] [Full Text]  
• Kearney, D., Byrne, A., Crean, P., Cox, D., Fitzgerald, D. J. (2004). Optimal suppression of thromboxane a2 formation by aspirin during percutaneous transluminal coronary angioplasty: no additional effect of a selective cyclooxygenase-2 inhibitor. J Am Coll Cardiol 43: 526-531 [Abstract] [Full Text]  
• Colombo, A., Sangiorgi, G. (2004). The monocyte: the key in the lock to reduce stent hyperplasia?. J Am Coll Cardiol 43: 24-26 [Full Text]  
• Chan, A. W., Moliterno, D. J., Berger, P. B., Stone, G. W., DiBattiste, P. M., Yakubov, S. L., Sapp, S. K., Wolski, K., Bhatt, D. L., Topol, E. J., TARGET Investigators, (2003). Triple antiplatelet therapy during percutaneous coronary intervention is associated withimproved outcomes including one-year survival: Results from the do tirofiban and reoprogive similar efficacy outcome trial (TARGET). J Am Coll Cardiol 42: 1188-1195 [Abstract] [Full Text]  
• Dee, S. V., Samady, H. (2003). Evolving Strategies for the Prevention and Treatment of Coronary Restenosis. SEMIN CARDIOTHORAC VASC ANESTH 7: 281-293 [Abstract]  
• Levine, G. N., Kern, M. J., Berger, P. B., Brown, D. L., Klein, L. W., Kereiakes, D. J., Sanborn, T. A., Jacobs, A. K., for the American Heart Association Diagnostic and, (2003). Management of Patients Undergoing Percutaneous Coronary Revascularization. ANN INTERN MED 139: 123-136 [Abstract] [Full Text]  
• Smith, T. P., Alshafie, T. A., Cruz, C. P., Fan, C.-Y., Brown, A. T., Wang, Y., Eidt, J. F., Moursi, M. M. (2003). Saratin, an Inhibitor of Collagen-Platelet Interaction, Decreases Venous Anastomotic Intimal Hyperplasia in a Canine Dialysis Access Model. VASC ENDOVASCULAR SURG 37: 259-269 [Abstract]  
• Mehta, S. R., Yusuf, S. (2003). Short- and long-term oral antiplatelet therapy in acute coronary syndromes and percutaneous coronary intervention. J Am Coll Cardiol 41: 79S-88S [Abstract] [Full Text]  
• Sopko, G. (2002). Preventing Cardiac Events and Restenosis After Percutaneous Coronary Intervention. JAMA 287: 3259-3261 [Full Text]  
• Cheng, Y., Austin, S. C., Rocca, B., Koller, B. H., Coffman, T. M., Grosser, T., Lawson, J. A., FitzGerald, G. A. (2002). Role of Prostacyclin in the Cardiovascular Response to Thromboxane A2. Science 296: 539-541 [Abstract] [Full Text]  
• Smith, S. C. Jr, Dove, J. T., Jacobs, A. K., Ward Kennedy, J., Kereiakes, D., Kern, M. J., Kuntz, R. E., Popma, J. J., Schaff, H. V., Williams, D. O., Gibbons, R. J., Alpert, J. P., Eagle, K. A., Faxon, D. P., Fuster, V., Gardner, T. J., Gregoratos, G., Russell, R. O., Smith, S. C. Jr (2001). ACC/AHA guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines): A report of the American College of Cardiology/ American Heart Association Task Force on practice guidelines (Committee to revise the 1993 guidelines for percutaneous transluminal coronary angioplasty) endorsed by the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 37: 2239-2239 [Full Text]  
• Salame, M.Y, Verheye, S, Crocker, I.R, Chronos, N.A.F, Robinson, K.A, King, S.B III (2001). Intracoronary radiation therapy. Eur Heart J 22: 629-647  
• Voisard, R., Fischer, R., O{beta}wald, M., Voglic, S., Baur, R., Susa, M., Koenig, W., Hombach, V. (2001). Aspirin (5 mmol/L) Inhibits Leukocyte Attack and Triggered Reactive Cell Proliferation in a 3D Human Coronary In Vitro Model. Circulation 103: 1688-1694 [Abstract] [Full Text]  
• Steinhubl, S. R., Ellis, S. G., Wolski, K., Lincoff, A. M., Topol, E. J. (2001). Ticlopidine Pretreatment Before Coronary Stenting Is Associated With Sustained Decrease in Adverse Cardiac Events : Data From the Evaluation of Platelet IIb/IIIa Inhibitor for Stenting (EPISTENT) Trial. Circulation 103: 1403-1409 [Abstract] [Full Text]  
• Iuliano, L., Pratico, D., Greco, C., Mangieri, E., Scibilia, G., FitzGerald, G. A., Violi, F. (2001). Angioplasty increases coronary sinus F2-isoprostane formation: evidence for in vivo oxidative stress during PTCA. J Am Coll Cardiol 37: 76-80 [Abstract] [Full Text]  
• Fontana, L., Giagulli, C., Minuz, P., Lechi, A., Laudanna, C. (2001). 8-Iso-PGF2{{alpha}} Induces {beta}2-Integrin-Mediated Rapid Adhesion of Human Polymorphonuclear Neutrophils : A Link Between Oxidative Stress and Ischemia/Reperfusion Injury. Arterioscler. Thromb. Vasc. Bio. 21: 55-60 [Abstract] [Full Text]  
• Popma, J. J., Ohman, E. M., Weitz, J., Lincoff, A. M., Harrington, R. A., Berger, P. (2001). Antithrombotic Therapy in Patients Undergoing Percutaneous Coronary Intervention. Chest 119 : 321S-336S [Full Text]  
• Verheugt, F.W.A. (2000). How hot is inflammation in acute coronary syndrom?. Eur Heart J 21: 1990-1992  
• Lincoff, A. M., LeNarz, L. A., Despotis, G. J., Smith, P. K., Booth, J. E., Raymond, R. E., Sapp, S. K., Cabot, C. F., Tcheng, J. E., Califf, R. M., Effron, M. B., Topol, E. J. (2000). Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Ann. Thorac. Surg. 70: 516-526 [Abstract] [Full Text]  
• Pratico, D., Cheng, Y., FitzGerald, G. A. (2000). TP or Not TP: Primary Mediators in a Close Runoff?. Arterioscler. Thromb. Vasc. Bio. 20: 1695-1698 [Full Text]  
• Lincoff, A. M., Califf, R. M., Topol, E. J. (2000). Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease. J Am Coll Cardiol 35: 1103-1115 [Abstract] [Full Text]  
• Awtry, E. H., Loscalzo, J. (2000). Aspirin. Circulation 101: 1206-1218 [Full Text]  
• Chandrasekar, B., Tanguay, J.-F. (2000). Platelets and restenosis. J Am Coll Cardiol 35: 555-562 [Abstract] [Full Text]  
• Brodison, A., Katira, R., More, R. S, Chauhan, A. (2000). Current practice: Antiplatelet use in interventional cardiology. Postgrad. Med. J. 76: 70-79 [Abstract] [Full Text]  
• Wiegman, P. J., Barry, W. L., McPherson, J. A., McNamara, C. A., Gimple, L. W., Sanders, J. M., Bishop, G. G., Powers, E. R., Ragosta, M., Owens, G. K., Sarembock, I. J. (2000). All-trans-Retinoic Acid Limits Restenosis After Balloon Angioplasty in the Focally Atherosclerotic Rabbit : A Favorable Effect on Vessel Remodeling. Arterioscler. Thromb. Vasc. Bio. 20: 89-95 [Abstract] [Full Text]  
• Borries, M., Heins, M., Fischer, Y., Stiegler, H., Peters, A., Reinauer, H., Schoebel, F. C., Strauer, B. E., Leschke, M. (1999). Changes of hemostasis, endogenous fibrinolysis, platelet activation and endothelins after percutaneous transluminal coronary angioplasty in patients with stable angina. J Am Coll Cardiol 34: 486-493 [Abstract] [Full Text]  
• Tsuchikane, E., Fukuhara, A., Kobayashi, T., Kirino, M., Yamasaki, K., Kobayashi, T., Izumi, M., Otsuji, S., Tateyama, H., Sakurai, M., Awata, N. (1999). Impact of Cilostazol on Restenosis After Percutaneous Coronary Balloon Angioplasty. Circulation 100: 21-26 [Abstract] [Full Text]  
• Natarajan, R., Pei, H., Gu, J.-L., Sarma, J. M., Nadler, J. (1999). Evidence for 12-lipoxygenase induction in the vessel wall following balloon injury. Cardiovasc Res 41: 489-499 [Abstract] [Full Text]  
• Labinaz, M., Pels, K., Hoffert, C., Aggarwal, S., O'Brien, E. R (1999). Time course and importance of neoadventitial formation in arterial remodeling following balloon angioplasty of porcine coronary arteries. Cardiovasc Res 41: 255-266 [Abstract] [Full Text]  
• Azar, R. R., McKay, R. G., Thompson, P. D., Hirst, J. A., Mitchell, J. F., Fram, D. B., Waters, D. D., Kiernan, F. J. (1998). Abciximab in primary coronary angioplasty for acute myocardial infarction improves short- and medium-term outcomes. J Am Coll Cardiol 32: 1996-2002 [Abstract] [Full Text]  
• Stouffer, G. A., Hu, Z., Sajid, M., Li, H., Jin, G., Nakada, M. T., Hanson, S. R., Runge, M. S. (1998). ß3 Integrins Are Upregulated After Vascular Injury and Modulate Thrombospondin- and Thrombin-Induced Proliferation of Cultured Smooth Muscle Cells. Circulation 97: 907-915 [Abstract] [Full Text]  
• Jenkins, G. M., Crow, M. T., Bilato, C., Gluzband, Y., Ryu, W.-S., Li, Z., Stetler-Stevenson, W., Nater, C., Froehlich, J. P., Lakatta, E. G., Cheng, L. (1998). Increased Expression of Membrane-Type Matrix Metalloproteinase and Preferential Localization of Matrix Metalloproteinase-2 to the Neointima of Balloon-Injured Rat Carotid Arteries. Circulation 97: 82-90 [Abstract] [Full Text]  
• Altman, R. (1998). Controversies in Antithrombotic Therapy in Cardiovascular Diseases. CLIN APPL THROMB HEMOST 4: 11-24 [Abstract]  
• Pakala, R., Willerson, J. T., Benedict, C. R. (1997). Effect of Serotonin, Thromboxane A2, and Specific Receptor Antagonists on Vascular Smooth Muscle Cell Proliferation. Circulation 96: 2280-2286 [Abstract] [Full Text]  
• Kugelmass, A. D., Raskob, G. E. (1997). Antithrombotic Therapy in Patients Undergoing Coronary Angioplasty or Coronary Stent Placement. CLIN APPL THROMB HEMOST 3: S24-S31  
• Fischman, D. L., Savage, M. P. (1997). The Platelet, the Patient, and Periprocedural Infarction During Percutaneous Transluminal Coronary Angioplasty. JAMA 278: 518-519 [Abstract]  
• Tardif, J.-C., Cote, G., Lesperance, J., Bourassa, M., Lambert, J., Doucet, S., Bilodeau, L., Nattel, S., de Guise, P., The Multivitamins and Probucol Study Group, (1997). Probucol and Multivitamins in the Prevention of Restenosis after Coronary Angioplasty. NEJM 337: 365-372 [Abstract] [Full Text]  
• Oltrona, L., Eisenberg, P. R., Lasala, J. M., Sewall, D. J., Shelton, M. E., Winters, K. J. (1996). Association of Heparin-Resistant Thrombin Activity With Acute Ischemic Complications of Coronary Interventions. Circulation 94: 2064-2071 [Abstract] [Full Text]  
• Adrie, C., Bloch, K. D., Moreno, P. R., Hurford, W. E., Guerrero, J. L., Holt, R., Zapol, W. M., Gold, H. K., Semigran, M. J. (1996). Inhaled Nitric Oxide Increases Coronary Artery Patency After Thrombolysis. Circulation 94: 1919-1926 [Abstract] [Full Text]  
• Brown, D. M., Kania, N. M., Choi, E. T., Lantieri, L. A., Pasia, E. N., Wun, T.-C., Khouri, R. K. (1996). Local Irrigation With Tissue Factor Pathway Inhibitor Inhibits Intimal Hyperplasia Induced by Arterial Interventions. Arch Surg 131: 1086-1090 [Abstract]  
• Narins, C. R., Hillegass, W. B. Jr, Nelson, C. L., Tcheng, J. E., Harrington, R. A., Phillips, H. R., Stack, R. S., Califf, R. M. (1996). Relation Between Activated Clotting Time During Angioplasty and Abrupt Closure. Circulation 93: 667-671 [Abstract] [Full Text]  
• Savage, M. P., Goldberg, S., Bove, A. A., Deutsch, E., Vetrovec, G., Macdonald, R. G., Bass, T., Margolis, J. R., Whitworth, H. B., Taussig, A., Hirshfeld, J. W., Cowley, M., Hill, J. A., Marks, R. G., Fischman, D. L., Handberg, E., Herrmann, H., Pepine, C. J. (1995). Effect of Thromboxane A2 Blockade on Clinical Outcome and Restenosis After Successful Coronary Angioplasty : Multi-Hospital Eastern Atlantic Restenosis Trial (M-HEART II). Circulation 92: 3194-3200 [Abstract] [Full Text]  
• Speidel, C. M., Eisenberg, P. R., Ruf, W., Edgington, T. S., Abendschein, D. R. (1995). Tissue Factor Mediates Prolonged Procoagulant Activity on the Luminal Surface of Balloon-Injured Aortas in Rabbits. Circulation 92: 3323-3330 [Abstract] [Full Text]  
• Serruys, P. W., Herrman, J.-P. R., Simon, R., Rutsch, W., Bode, C., Laarman, G.-J., van Dijk, R., van den Bos, A. A., Umans, V. A.W.M., Fox, K. A.A., Close, P., Deckers, J. W., The Helvetica Investigators, (1995). A Comparison of Hirudin with Heparin in the Prevention of Restenosis after Coronary Angioplasty. NEJM 333: 757-764 [Abstract] [Full Text]  
• Zahger, D., Fishbein, M. C., Garfinkel, L. I., Shah, P. K., Forrester, J. S., Regnstrom, J., Yano, J., Cercek, B. (1995). VCL, an Antagonist of the Platelet GP1b Receptor, Markedly Inhibits Platelet Adhesion and Intimal Thickening After Balloon Injury in the Rat. Circulation 92: 1269-1273 [Abstract] [Full Text]  
• Rogers, C., Edelman, E. R. (1995). Endovascular Stent Design Dictates Experimental Restenosis and Thrombosis. Circulation 91: 2995-3001 [Abstract] [Full Text]  
• Tcheng, J. E., Harrington, R. A., Kottke-Marchant, K., Kleiman, N. S., Ellis, S. G., Kereiakes, D. J., Mick, M. J., Navetta, F. I., Smith, J. E., Worley, S. J., Miller, J. A., Joseph, D. M., Sigmon, K. N., Kitt, M. M., du Mee, C. P., Califf, R. M., Topol, E. J. (1995). Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial of the Platelet Integrin Glycoprotein IIb/IIIa Blocker Integrelin in Elective Coronary Intervention. Circulation 91: 2151-2157 [Abstract] [Full Text]  
• Minar, E., Ahmadi, A., Koppensteiner, R., Maca, Th., Stumpflen, A., Ugurluoglu, A., Ehringer, H. (1995). Comparison of Effects of High-Dose and Low-Dose Aspirin on Restenosis After Femoropopliteal Percutaneous Transluminal Angioplasty. Circulation 91: 2167-2173 [Abstract] [Full Text]  
• Turner, N. A., Moake, J. L., Kamat, S. G., Schafer, A. I., Kleiman, N. S., Jordan, R., McIntire, L. V. (1995). Comparative Real-Time Effects on Platelet Adhesion and Aggregation Under Flowing Conditions of In Vivo Aspirin, Heparin, and Monoclonal Antibody Fragment Against Glycoprotein IIb-IIIa. Circulation 91: 1354-1362 [Abstract] [Full Text]  
• Konstantopoulos, K., Kamat, S. G., Schafer, A. I., Banez, E. I., Jordan, R., Kleiman, N. S., Hellums, J. D. (1995). Shear-Induced Platelet Aggregation Is Inhibited by In Vivo Infusion of an Anti–Glycoprotein IIb/IIIa Antibody Fragment, c7E3 Fab, in Patients Undergoing Coronary Angioplasty. Circulation 91: 1427-1431 [Abstract] [Full Text]  
• de Groote, P., Bauters, C., McFadden, E. P., Lablanche, J.-M., Leroy, F., Bertrand, M. E. (1995). Local Lesion-Related Factors and Restenosis After Coronary Angioplasty : Evidence From a Quantitative Angiographic Study in Patients With Unstable Angina Undergoing Double-Vessel Angioplasty. Circulation 91: 968-972 [Abstract] [Full Text]  
• Fischman, D. L., Leon, M. B., Baim, D. S., Schatz, R. A., Savage, M. P., Penn, I., Detre, K., Veltri, L., Ricci, D., Nobuyoshi, M., Cleman, M., Heuser, R., Almond, D., Teirstein, P. S., Fish, R. D., Colombo, A., Brinker, J., Moses, J., Shaknovich, A., Hirshfeld, J., Bailey, S., Ellis, S., Rake, R., Goldberg, S., The Stent Restenosis Study Investigators, (1994). A Randomized Comparison of Coronary-Stent Placement and Balloon Angioplasty in the Treatment of Coronary Artery Disease. NEJM 331: 496-501 [Abstract] [Full Text]  
• The EPIC Investigators, (1994). Use of a Monoclonal Antibody Directed against the Platelet Glycoprotein IIb/IIIa Receptor in High-Risk Coronary Angioplasty. NEJM 330: 956-961 [Abstract] [Full Text]  
• Landau, C., Lange, R. A., Hillis, L. D. (1994). Percutaneous Transluminal Coronary Angioplasty. NEJM 330: 981-993 [Full Text]  
• (1994). Collaborative overview of randomised trials of antiplatelet therapy - II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. BMJ 308: 159-168 [Abstract] [Full Text]  
• Antiplatelet Trialists, (1994). Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various categories of patients. BMJ 308: 81-106 [Abstract] [Full Text]  
• Gapinski, J. P., VanRuiswyk, J. V., Heudebert, G. R., Schectman, G. S. (1993). Preventing Restenosis With Fish Oils Following Coronary Angioplasty: A Meta-analysis. Arch Intern Med 153: 1595-1601 [Abstract]  
• Harker, L. A., Bernstein, E. F., Dilley, R. B., Scala, T. E., Sise, M. J., Hye, R. J., Otis, S. M., Roberts, R. S., Michael, G. (1992). Failure of Aspirin plus Dipyridamole To Prevent Restenosis after Carotid Endarterectomy. ANN INTERN MED 116: 731-736 [Abstract]  
• Bowles, M. H., Klonis, D., Plavac, T. G., Gonzales, B., Francisco, D. A., Roberts, R. W., Boxberger, G. R., Poliner, L. R., Galichia, J. P. (1991). EPA in the Prevention of Restenosis Post PTCA. ANGIOLOGY 42: 187-194 [Abstract]  
• Wong, J. B., Sonnenberg, F. A., Salem, D. N., Pauker, S. G. (1990). Myocardial Revascularization for Chronic Stable Angina: Analysis of the Role of Percutaneous Transluminal Coronary Angioplasty Based on Data Available in 1989. ANN INTERN MED 113: 852-871 [Abstract]  
• Becker, R. C., Alpert, J. S. (1990). The Impact of Medical Therapy on Hemorrhagic Complications Following Coronary Artery Bypass Grafting. Arch Intern Med 150: 2016-2021 [Abstract]  
• Nabel, E., Plautz, G, Nabel, G. (1990). Site-specific gene expression in vivo by direct gene transfer into the arterial wall. Science 249: 1285-1288 [Abstract]  
• Dalman, R. L., Taylor, L. M. Jr, Porter, J. M. (1990). Current Status of Extracoronary Endovascular Procedures. PERSPECT VASC SURG ENDOVASC THER 3: 1-24  
• Clagett, G. P. (1990). Antithrombotic Drugs and Vascular Surgery. PERSPECT VASC SURG ENDOVASC THER 3: 79-102  
• Nabel, E., Plautz, G, Boyce, F., Stanley, J., Nabel, G. (1989). Recombinant gene expression in vivo within endothelial cells of the arterial wall. Science 244: 1342-1344 [Abstract]  
• (1988). ASPIRIN-DIPYRIDAMOLE REDUCES MORTALITY FROM ANGIOPLASTY. JWatch General 1988: 6-6 [Full Text]